Table 1.
Characteristic | |
---|---|
Patients, n | 110 |
Age, years | |
<60 | 41 (37.3) |
≥60 | 69 (62.7) |
FIGO, grade | |
I/II | 36 (32.7) |
III/IV | 74 (67.3) |
Lymph node status | |
Negative | 59 (53.6) |
Positive | 51 (46.4) |
Nuclear grading | |
Low-grade | 41 (37.3) |
High-grade | 69 (62.8) |
Histology | |
Serous | 76 (69.1) |
Mucinous | 10 (9.1) |
Endometrioid | 6 (5.5) |
Clear cell | 2 (1.8) |
Others | 16 (14.5) |
Ascites (ml) | |
<500 | 33 (30.0) |
≥500 | 36 (32.7) |
None | 38 (34.5) |
No data | 3 (2.7) |
Recurrence | |
Yes | 57 (51.8) |
No | 53 (48.2) |
Data presented as n (%)
FIGO, International Federation of Gynaecology and Obstetrics staging system (I/II = low/moderate grade tumours, III/IV = high grade/undifferentiated)